6YND image
Entry Detail
PDB ID:
6YND
Title:
GAPDH purified from the supernatant of HEK293F cells: crystal form 1 of 4.
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2020-04-13
Release Date:
2020-05-06
Method Details:
Experimental Method:
Resolution:
1.53 Å
R-Value Free:
0.19
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Glyceraldehyde-3-phosphate dehydrogenase
Mutations:C152X
Chain IDs:A, B, C, D, E, F, G, H
Chain Length:335
Number of Molecules:8
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CSU A CYS modified residue
Ligand Molecules
Primary Citation
Partial catalytic Cys oxidation of human GAPDH to Cys-sulfonic acid.
Wellcome Open Res 5 114 114 (2020)
PMID: 32802964 DOI: 10.12688/wellcomeopenres.15893.2

Abstact

Background: n-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) catalyses the NAD +-dependent oxidative phosphorylation of n-glyceraldehyde-3-phosphate to 1,3-diphospho-n-glycerate and its reverse reaction in glycolysis and gluconeogenesis. Methods: Four distinct crystal structures of human n-Glyceraldehyde-3-phosphate dehydrogenase (HsGAPDH) have been determined from protein purified from the supernatant of HEK293F human epithelial kidney cells. Results: X-ray crystallography and mass-spectrometry indicate that the catalytic cysteine of the protein (HsGAPDH Cys152) is partially oxidised to cysteine S-sulfonic acid. The average occupancy for the Cys152-S-sulfonic acid modification over the 20 crystallographically independent copies of HsGAPDH across three of the crystal forms obtained is 0.31±0.17. Conclusions: The modification induces no significant structural changes on the tetrameric enzyme, and only makes aspecific contacts to surface residues in the active site, in keeping with the hypothesis that the oxidising conditions of the secreted mammalian cell expression system result in HsGAPDH catalytic cysteine S-sulfonic acid modification and irreversible inactivation of the enzyme.

Legend

Protein

Chemical

Disease

Primary Citation of related structures